Terms: = Bone cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Diagnosis
69 results:
1. SMARCB1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma.
Argyris PP; Challa B; Satturwar S; VanKoevering KK; Wakely PE
Head Neck Pathol; 2024 Jan; 18(1):1. PubMed ID: 38236556
[TBL] [Abstract] [Full Text] [Related]
2. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
[TBL] [Abstract] [Full Text] [Related]
3. idh-negative chondrosarcoma with metachronous dedifferentiation only in the metastatic site-A diagnostic pitfall.
Sekita T; Yoshida A; Kawai A; Ichikawa H; Kobayashi E
Genes Chromosomes Cancer; 2023 Dec; 62(12):755-760. PubMed ID: 37732625
[TBL] [Abstract] [Full Text] [Related]
4. diagnosis- and Prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
5. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
Tefferi A; Alkhateeb H; Gangat N
Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
[TBL] [Abstract] [Full Text] [Related]
6. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
[TBL] [Abstract] [Full Text] [Related]
7. Conventional chondrosarcoma of the rib cage and sternum: clinicopathological and molecular analysis of 27 patients treated at a single institution.
Abdulfatah E; Rottmann D; Morag Y; Pantanowitz L; Udager AM; Hao W; Lucas DR
Hum Pathol; 2023 Jun; 136():63-74. PubMed ID: 37019410
[TBL] [Abstract] [Full Text] [Related]
8. Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
Baranwal A; Chhetri R; Yeung D; Clark M; Shah S; Litzow MR; Hogan WJ; Mangaonkar A; Alkhateeb HB; Singhal D; Cibich A; Bardy P; Kok CH; Hiwase DK; Shah MV
Bone Marrow Transplant; 2023 Jul; 58(7):769-776. PubMed ID: 37012415
[TBL] [Abstract] [Full Text] [Related]
9. Chondrosarcoma Skull Base: A Case Report.
Bharti JN; Elhence P; Bhaskar S; Garg PK
Curr Med Imaging; 2023; 19(11):1346-1350. PubMed ID: 36748815
[TBL] [Abstract] [Full Text] [Related]
10. Biology and Management of High-Grade Chondrosarcoma: An Update on Targets and Treatment Options.
Tlemsani C; Larousserie F; De Percin S; Audard V; Hadjadj D; Chen J; Biau D; Anract P; Terris B; Goldwasser F; Pasmant E; Boudou-Rouquette P
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674874
[TBL] [Abstract] [Full Text] [Related]
11. Molecular and immunohistochemical testing of bone tumours: review and update.
Kovacs SK; Manassaporn A; Nielsen GP; Hung YP
Histopathology; 2023 May; 82(6):794-811. PubMed ID: 36424903
[TBL] [Abstract] [Full Text] [Related]
12. A specific immune signature for predicting the prognosis of glioma patients with idh1-mutation and guiding immune checkpoint blockade therapy.
Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
[TBL] [Abstract] [Full Text] [Related]
13. Impact of idh1 and idh2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
Kunadt D; Stasik S; Metzeler KH; Röllig C; Schliemann C; Greif PA; Spiekermann K; Rothenberg-Thurley M; Krug U; Braess J; Krämer A; Hochhaus A; Scholl S; Hilgendorf I; Brümmendorf TH; Jost E; Steffen B; Bug G; Einsele H; Görlich D; Sauerland C; Schäfer-Eckart K; Krause SW; Hänel M; Hanoun M; Kaufmann M; Wörmann B; Kramer M; Sockel K; Egger-Heidrich K; Herold T; Ehninger G; Burchert A; Platzbecker U; Berdel WE; Müller-Tidow C; Hiddemann W; Serve H; Stelljes M; Baldus CD; Neubauer A; Schetelig J; Thiede C; Bornhäuser M; Middeke JM; Stölzel F;
J Hematol Oncol; 2022 Sep; 15(1):126. PubMed ID: 36064577
[TBL] [Abstract] [Full Text] [Related]
14. Juvenile granulosa cell tumor associated with Ollier disease.
Littrell LA; Inwards CY; Hazard FK; Wenger DE
Skeletal Radiol; 2023 Mar; 52(3):605-612. PubMed ID: 35296906
[TBL] [Abstract] [Full Text] [Related]
15. Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With idh Mutations: A Single Center Experience.
Ambinder A; Smith M; Tsai HL; Varadhan R; DeZern A; Dalton W; Gocke C; Webster J; Gondek L; Gojo I; Ali SA; Huff CA; Swinnen L; Wagner-Johnston N; Showel M; Prince G; Borrello I; Bolaños-Meade J; Luznik L; Jain T; Imus P; Fuchs E; Ambinder R; Gladstone DE; Levis M; Jones R; Ghiaur G; Smith BD
Clin Lymphoma Myeloma Leuk; 2022 Apr; 22(4):260-269. PubMed ID: 34750086
[TBL] [Abstract] [Full Text] [Related]
16. MYC overexpression is associated with an early disease progression from MDS to AML.
Gajzer D; Logothetis CN; Sallman DA; Calon G; Babu A; Chan O; Vincelette ND; Volpe VO; Al Ali NH; Basra P; Talati C; Kuykendall AT; Mo Q; Padron E; Sweet K; Komrokji RS; Lancet JE; Yun S; Zhang L
Leuk Res; 2021 Dec; 111():106733. PubMed ID: 34749168
[TBL] [Abstract] [Full Text] [Related]
17. Osteosarcoma: Old and New Challenges.
Yoshida A
Surg Pathol Clin; 2021 Dec; 14(4):567-583. PubMed ID: 34742481
[TBL] [Abstract] [Full Text] [Related]
18. ASXL1 and STAG2 are common mutations in GATA2 deficiency patients with bone marrow disease and myelodysplastic syndrome.
West RR; Calvo KR; Embree LJ; Wang W; Tuschong LM; Bauer TR; Tillo D; Lack J; Droll S; Hsu AP; Holland SM; Hickstein DD
Blood Adv; 2022 Feb; 6(3):793-807. PubMed ID: 34529785
[TBL] [Abstract] [Full Text] [Related]
19. Intracranial high-grade glioma with malignant progression of spinal intramedullary metastasis: an atypical presentation with review of literature.
Siroya HL; Bhagavatula ID; Bhat DI; Sadashiva N
Br J Neurosurg; 2023 Dec; 37(6):1495-1501. PubMed ID: 34396889
[TBL] [Abstract] [Full Text] [Related]
20. Intracranial myeloid sarcoma presentation in distant acute myeloid leukemia remission.
Lee D; Omofoye OA; Karnati T; Graff JP; Shahlaie K
J Clin Neurosci; 2021 Jul; 89():158-160. PubMed ID: 34119261
[TBL] [Abstract] [Full Text] [Related]
[Next]
